Navigation Links
Exubera could mean the end of an insulin injection era for diabetics

Diabetes and cancer remain the most feared diseases all around the world. Researchers have now come up with an insulin inhaler, potentially offering adult diabetics an alternative to injections// for controlling their blood sugar. The drug is yet to be approved by the FDA.

If approved, the drug, known as Exubera, would mean an end to the insulin injections taken by millions worldwide. The product works by releasing an insulin-powder cloud inhaled via a handheld plastic machine similar to the inhalers used for asthma and allergy. The drug has been in development for a decade and is now backed by a joint venture between Pfizer, Sanofi-Aventis and Nektar Therapeutics.

Pfizer presented several studies showing Exubera controlled blood sugar as well as insulin shots for up to two years in patients with both forms of diabetes. Questions remain about whether adult Type 1 diabetics can expect to achieve tight glycemic control with Exubera.

Up to two-thirds of all diabetics do not adequately control their blood sugar, according to the American Academy of Clinical Endocrinologists. Poor control over the long term can lead to blood vessel and organ damage, blindness, and kidney failure and foot ailments.

Despite approval, many would still have to use needles, because the drug is not a replacement for the currently available longer-acting insulin. In addition, patients who smoke will be excluded from taking the drug, because of evidence that damage from cigarettes boosts patients` exposure to insulin.

'To have people rush to the this product saying, `I can throw away my syringes` ... is simply an incorrect message and that needs to be emphasized more,' said Dr. Paul D. Woolf, chief of medicine at Crozer Chester Medical Center in Upland, Pa., and acting chair of the advisory panel. I think the use of insulin without a needle, the siren call of that is almost irresistible,' said Rebecca W. Killion, the panel`s patient representative -- herself a diabetic. 'The practicality issue, though ... is huge.' The companies did not seek approval for adolescents and children -- two groups that could benefit greatly from a needle-free product. It has been proposed to restart pediatric studies with special emphasis on breathing problems.
'"/>




Related medicine news :

1. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
2. Exubera is effective in diabetes patients with cold or flu
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... WASHINGTON , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, ... to Washington, D.C. offering free MRI brain scans to the public.Where:  ... – will be parked at 501 K Street NW, Washington, D.C.What:BTF brings ...
Breaking Medicine Technology: